Hjem › Brystkreft › California › Newport Beach
Kliniske studier for Brystkreft i Newport Beach, CA
16 studier for Brystkreft søker deltakere på steder i og rundt Newport Beach (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekruttererFase 1
- Research Site, Newport Beach
IKS014 in Advanced Solid Tumors That Express HER2
RekruttererFase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RekruttererFase 3
- Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Hoag Memorial Hospital Presbyterian ( Site 0010), Newport Beach
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruttererFase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekruttererFase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruttererFase 1
- Hoag Family Cancer Institute, Newport Beach
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruttererFase 2/3
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
RekruttererFase 1
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- HOAG Memorial Hospital Presbyterian, Newport Beach
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
RekruttererObservasjonsstudie
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruttererFase 3
- City of Hope Newport Beach, Newport Beach
Perioperative Mindfulness Proposal
Rekrutterer
- Hoag Memorial Hospital Presbyterian, Newport Beach
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Newport Beach
- Ikke-småcellet lungekreft14 studier
- Metastatisk kreft10 studier
- KOLS9 studier
- Eggstokkreft9 studier
- Endometriekreft7 studier
- Lungekreft7 studier
- Kolorektal kreft6 studier
- Prostatakreft6 studier
- Tripelnegativ brystkreft6 studier
- Kreft (alle typer)6 studier
- Plateepitelcancer i hode og hals5 studier
- Nyrekreft (nyrecellekarcinom)5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.